Cesar Libanati
0000-0003-1427-7839
3 papers found
Refreshing results…
Preparing the Leaders of Tomorrow: Learnings from a Two-Year Community of Practice in Fragility Fractures
Romosozumab Followed by Antiresorptive Treatment Increases the Probability of Achieving Bone Mineral Density Treatment Goals
T ‐Score as an Indicator of Fracture Risk During Treatment With Romosozumab or Alendronate in the ARCH Trial
Missing publications? Search for publications with a matching author name.